Table 4 |
||||||||||||
|
Correlation of histological and tumor biological factors |
||||||||||||
|
p-value |
||||||||||||
|
|
||||||||||||
|
Tumor size |
LN pos |
G = 3 |
ER |
LA |
HA |
BM |
HER2 |
HER2F |
Top IIa |
Ki67 |
p53 |
|
|
|
||||||||||||
|
Tumor size |
- |
<0.001 |
<0.001 |
0.50 |
<0.001 |
0.053 |
0.063 |
0.50 |
0.31 |
0.09 |
0.61 |
0.44 |
|
LN pos |
<0.001 |
- |
0.001 |
<0.001 |
<0.001 |
<0.001 |
0.29 |
0.47 |
0.17 |
0.16 |
0.17 |
0.45 |
|
G = 3 |
<0.001 |
0.001 |
- |
0.10 |
0.001 |
0.90 |
0.65 |
0.11 |
0.8 |
0.71 |
0.80 |
0.17 |
|
ER neg |
0.50 |
<0.001 |
0.10 |
- |
<0.001 |
<0.001 |
0.85 |
0.29 |
0.12 |
0.026 |
0.034 |
0.03 |
|
LA |
<0.001 |
<0.001 |
0.001 |
<0.001 |
- |
<0.001 |
0.38 |
0.64 |
0.57 |
0.441 |
0.36 |
0.98 |
|
HA |
0.053 |
<0.001 |
0.90 |
<0.001 |
<0.001 |
- |
0.58 |
0.01 |
0.66 |
0.89 |
0.87 |
0.39 |
|
BM |
0.063 |
0.29 |
0.65 |
0.85 |
0.38 |
0.58 |
- |
0.82 |
0.063 |
0.47 |
0.86 |
0.67 |
|
HER2 |
0.50 |
0.47 |
0.11 |
0.29 |
0.64 |
0.01 |
0.82 |
- |
<0.001 |
0.06 |
0.031 |
<0.001 |
|
HER2F |
0.31 |
0.17 |
0.80 |
0.12 |
0.57 |
0.66 |
0.063 |
<0.001 |
- |
0.45 |
0.55 |
0.35 |
|
Top IIa |
0.09 |
0.16 |
0.71 |
0.026 |
0.441 |
0.89 |
0.47 |
0.06 |
0.45 |
- |
0.002 |
<0.001 |
|
Ki67 |
0.61 |
0.17 |
0.80 |
0.034 |
0.36 |
0.87 |
0.86 |
0.031 |
0.55 |
0.002 |
- |
0.004 |
|
P53 |
0.44 |
0.45 |
0.17 |
0.03 |
0.98 |
0.39 |
0.67 |
<0.001 |
0.35 |
<0.001 |
0.004 |
- |
|
|
||||||||||||
|
BM, bone marrow; ER, estrogen receptor; HA, hemangiosis; HER2 = human epithelial growth factor receptor 2; HER2F, HER2 FISH; LA, lymphangiosis; LN, lymph node; Top IIa = topoisomerase IIα. |
||||||||||||
|
Schindlbeck et al. Breast Cancer Research 2005 7:R1174 doi:10.1186/bcr1360 |
||||||||||||
